Puma Biotechnology, Inc. (PBYI)
9.55
+0.14
(+1.49%)
USD |
NASDAQ |
Sep 04, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Debt to Equity Ratio : 0.0348 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0348 |
| March 31, 2026 | 0.1242 |
| December 31, 2025 | 0.219 |
| September 30, 2025 | 0.3561 |
| June 30, 2025 | 0.4701 |
| March 31, 2025 | 0.6355 |
| December 31, 2024 | 0.8041 |
| September 30, 2024 | 1.215 |
| June 30, 2024 | 2.032 |
| March 31, 2024 | 2.172 |
| December 31, 2023 | 2.086 |
| September 30, 2023 | 2.897 |
| June 30, 2023 | 3.715 |
| March 31, 2023 | 4.396 |
| December 31, 2022 | 5.289 |
| September 30, 2022 | 5.186 |
| June 30, 2022 | 5.852 |
| March 31, 2022 | 16.25 |
| December 31, 2021 | -47.69 |
| September 30, 2021 | -10.73 |
| June 30, 2021 | 4.116 |
| March 31, 2021 | 7.370 |
| December 31, 2020 | -20.32 |
| September 30, 2020 | -266.59 |
| June 30, 2020 | 5.152 |
| Date | Value |
|---|---|
| March 31, 2020 | 12.84 |
| December 31, 2019 | 6.885 |
| September 30, 2019 | 6.987 |
| June 30, 2019 | 5.501 |
| March 31, 2019 | 4.134 |
| December 31, 2018 | 4.427 |
| September 30, 2018 | 2.637 |
| June 30, 2018 | 3.140 |
| March 31, 2018 | 0.8451 |
| December 31, 2017 | 0.9095 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arcutis Biotherapeutics, Inc. | 0.5174 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 192.74M |
| Total Liabilities (Quarterly) | 54.19M |
| Shareholders Equity (Quarterly) | 138.54M |
| Current Ratio | 2.912 |
| Net Debt Paydown Yield | 2.75% |